Clinical Trial Update: The IN.PACT SFA Clinical Study for the Treatment of Atherosclerotic Lesions in the Superficial Femoral Artery and/or Proximal Popliteal Artery Using the IN.PACT Admiral™ Drug-Eluting Balloon in a Chinese Patient Population [NA]

View source ↗

Summary

The IN.PACT Admiral paclitaxel-coated balloon trial in Chinese patients with atherosclerotic disease of the superficial femoral and proximal popliteal arteries …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis

Drugs mentioned

• IN.PACT Admiral Drug-Eluting Balloon (paclitaxel-coated balloon)

Snippet

Sponsor: Medtronic Endovascular | Conditions: Atherosclerosis | NA | Status: COMPLETED